Tag: chronic ischaemic cardiovascular disease

BioVentrix receives FDA expanded access program approval for ischemic heart failure treatment system

BioVentrix, a privately held medical device company focused on the development of less invasive ther...

Nearly 25% of chronic ischaemic heart disease patients dead or hospitalised in six months

¬†   Nearly a quarter of patients¬†with chronic ischaemic cardiovascular disease are dead o...